Product Information
ESCITALOPRAM OXALATE 5 MG/5 ML is a generic product labeled by Chartwell RX LLC, priced at $0.1426 per ML under NDC 62135072937. Its NADAC has been published 134 times since Mar 13, 2024.
FDA first approved this application on Jun 12, 2013. Its Orange Book therapeutic-equivalence code is AA.
Strength
5 mg/5mL
Manufacturer
Chartwell RX LLCNDC
62135072937
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
ESCITALOPRAM OXALATEApproval Type
Generic (ANDA)
FDA Application
ANDA090477FDA Approved
6/12/2013
TE Code
AA
On Market Since
6/12/2023
Pharmacological Classes
Price Statistics
The NADAC for ESCITALOPRAM OXALATE 5 MG/5 ML has been published 134 times since Mar 13, 2024, and over the history we have for it it has declined 50.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1426 per ML |
|---|---|
| All-time high | $0.2890 (Mar 13, 2024) |
| All-time low | $0.1182 (Jul 17, 2024) |
| 52-week high | $0.1969 |
| 52-week low | $0.1190 |
| Median price | $0.1668 |
| Average price | $0.1657 |
| Largest weekly change | +44.7% (Aug 21, 2024) |
| Weeks tracked | 134 |
| Tracking since | Mar 13, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Escitalopram Oral market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Escitalopram Oral market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Serotonin Reuptake Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ESCITALOPRAM OXALATE 5 MG/5 ML?
The current National Average Drug Acquisition Cost (NADAC) for ESCITALOPRAM OXALATE 5 MG/5 ML, manufactured by Chartwell RX LLC, is $0.1426 per ML (NDC 62135072937), effective Sep 30, 2026.
How has the price of ESCITALOPRAM OXALATE 5 MG/5 ML changed over time?
Over the history we have for it, the NADAC for ESCITALOPRAM OXALATE 5 MG/5 ML has declined 50.7%. It has been tracked across 134 weekly CMS publications since Mar 13, 2024.
What are the highest and lowest recorded NADAC prices for ESCITALOPRAM OXALATE 5 MG/5 ML?
Since Mar 13, 2024, the NADAC for ESCITALOPRAM OXALATE 5 MG/5 ML has ranged from a low of $0.1182 (Jul 17, 2024) to a high of $0.2890 (Mar 13, 2024), with a median of $0.1668 per ML.
Are there cheaper alternatives to ESCITALOPRAM OXALATE 5 MG/5 ML?
No other NADAC-published product currently shares the active ingredient and strength of ESCITALOPRAM OXALATE 5 MG/5 ML in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures ESCITALOPRAM OXALATE 5 MG/5 ML?
ESCITALOPRAM OXALATE 5 MG/5 ML (NDC 62135072937) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.